615 related articles for article (PubMed ID: 31954110)
21. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
[TBL] [Abstract][Full Text] [Related]
22. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
23. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
Lian H; Cheng Y; Wu X
Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
[TBL] [Abstract][Full Text] [Related]
24. Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice.
Yu J; Zong GN; Wu H; Zhang KQ
Acta Pharmacol Sin; 2019 Dec; 40(12):1544-1554. PubMed ID: 31270434
[TBL] [Abstract][Full Text] [Related]
25. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
26. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
Huang F; Sheng XX; Zhang HJ
Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
[TBL] [Abstract][Full Text] [Related]
27. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
Mitu GM; Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
[TBL] [Abstract][Full Text] [Related]
28. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
30.
Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
32. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
33. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
34. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
35. Grem2 mediates podocyte apoptosis in high glucose milieu.
Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
[TBL] [Abstract][Full Text] [Related]
36. Protein Kinase A/CREB Signaling Prevents Adriamycin-Induced Podocyte Apoptosis via Upregulation of Mitochondrial Respiratory Chain Complexes.
Xie K; Zhu M; Xiang P; Chen X; Kasimumali A; Lu R; Wang Q; Mou S; Ni Z; Gu L; Pang H
Mol Cell Biol; 2018 Jan; 38(1):. PubMed ID: 29038164
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
39. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
40. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
